Endocannabinoids in End Stage Renal Disease | NCT01477515 | Trialant
CompletedObservationalUpdated Aug 23, 2012
Endocannabinoids in End Stage Renal Disease
ClinicalTrials.gov ID
NCT01477515
Lead Sponsor
Indiana UniversityOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
30Actual
Last Update Posted
Aug 23, 2012Estimated
Start Date
Feb 2012
Brief Summary
To investigate the relationship between dietary intake, body habitus, and endocannabinoid levels in end stage renal disease patients as compared to matched controls.
End Stage Renal Disease
Nutrition
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
hemodialysis patient, able to give informed consent